Public Sector Pension Investment Board (PSP Investments)’s TG Therapeutics TGTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.9M Sell
452,817
-34,440
-7% -$1.41M 0.06% 243
2026
Q1
$16.2M Buy
487,257
+16,971
+4% +$506K 0.05% 328
2025
Q4
$14M Sell
470,286
-58,985
-11% -$1.93M 0.05% 321
2025
Q3
$19.1M Buy
529,271
+66,911
+14% +$2.2M 0.07% 216
2025
Q2
$16.6M Buy
462,360
+39,042
+9% +$1.45M 0.07% 205
2025
Q1
$16.7M Buy
423,318
+90,741
+27% +$3.05M 0.07% 197
2024
Q4
$10M Buy
332,577
+49,577
+18% +$1.42M 0.04% 334
2024
Q3
$6.62M Buy
+283,000
New +$6.18M 0.04% 363

Other funds holding TGTX

Public Sector Pension Investment Board (PSP Investments)'s TGTX Position: Q2 2026 in Review

Public Sector Pension Investment Board (PSP Investments) reduced its TG Therapeutics (TGTX) stake by 7.1% in Q2 2026, selling an estimated $1.41M and leaving 452,817 shares worth $24.9M. The position accounts for 0.06% of the portfolio, ranked #243.

Public Sector Pension Investment Board (PSP Investments) first reported a position in TGTX in Q3 2024 and has held it in 8 quarters since. 427 funds tracked by Wall St. Rank hold TGTX as of Q2 2026.

  • Public Sector Pension Investment Board (PSP Investments) held 452,817 shares of TG Therapeutics worth $24.9M as of Q2 2026.
  • Public Sector Pension Investment Board (PSP Investments) sold 34,440 TG Therapeutics shares in Q2 2026, an estimated $1.41M.
  • TG Therapeutics made up 0.06% of Public Sector Pension Investment Board (PSP Investments)'s portfolio in Q2 2026, its #243 holding.
  • Public Sector Pension Investment Board (PSP Investments) first reported a position in TG Therapeutics in Q3 2024 and has held it in 8 quarters since.
  • 427 funds tracked by Wall St. Rank held TG Therapeutics as of Q2 2026.

Based on Public Sector Pension Investment Board (PSP Investments)'s 13F filing for Q2 2026, filed 13 Aug 2026.